Xiaflex 0.9 MG vials
Ended Awarded
- Contract number
- SPE2DB25FPQR7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,682
Award facts
- Contract value 100% obligated
- $24,681.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $24,681.72 by the Defense Logistics Agency (DLA) on June 2, 2025, for the supply of Xiaflex 0.9 mg vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of June 24, 2025, and carries no set-aside designation. This award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a single-award vehicle valued at $499,999,999 and valid through November 2026, which authorizes the agency to issue delivery orders for a comprehensive range of pharmaceutical products.
The DLA, operating under the Department of Defense, utilizes the SPE2DB IDC to procure pharmaceutical supplies and medications for military healthcare facilities nationwide. Xiaflex, a specialty pharmaceutical product, supports the medical supply needs of Defense Department healthcare sites. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain through consistent contract performance, delivering branded and generic prescription drugs, biologics, medical consumables, and specialty medications to government healthcare systems. The company's federal contracting history demonstrates extensive experience with pharmaceutical distribution to military and federal agencies.
Quick answers
Who was awarded contract SPE2DB25FPQR7?
SPE2DB25FPQR7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FPQR7 worth?
The government has obligated $24,682 on SPE2DB25FPQR7.
Is contract SPE2DB25FPQR7 an order under another contract?
Yes. SPE2DB25FPQR7 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB25FPQR7 competed?
The extent of competition for SPE2DB25FPQR7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award